Introduction {#s1}
============

One of the core messages of the *Surviving Sepsis Campaign* is that to treat sepsis, physicians must first promptly identify sepsis.[@R1] This can be challenging. The systemic inflammatory response syndrome (SIRS) criteria are broad and non-specific, and biochemical markers require time to result. There is a general consensus that sepsis is a hyperdynamic state relating to increased cardiac output and decreased systemic vascular resistance (SVR).[@R1] Adjunct studies can identify patients with an increased cardiac output and decreased SVR, and prove valuable in the early diagnosis of sepsis. Invasive Swan Ganz monitoring can provide accurate information regarding cardiac output and SVR, but wide use for the diagnosis of sepsis is impractical, antiquated, and dangerous. An alternative to Swan Ganz catheterization is impedance cardiography.

Impedance cardiography was initially conceived in the 1940s by Jan Nyboer, who described the process of calculating blood volume using the resistance of blood in the thorax with electrical impedance.[@R2] In the 1960s, the National Aeronautics and Space Administration funded Kubicek *et al*[@R2] to develop a high-frequency, low-amplitude current to be applied to the chest using electrodes, and capturing that signal with additional electrodes capable of measuring impedance to flow of that current. This provided an indication of the quantity of blood ejected into the aorta (stroke volume) based on the wave form produced by voltage capture between systole and diastole.[@R4]

Compared with muscle, lung, fat, skin, bone, and air, blood has the lowest measurable electrical resistivity and the highest conductivity and permittivity.[@R5] Since an electrical current takes the path of least resistance, movement of a current applied to the thorax will mirror that of the path of blood flow.[@R5] The measurement of electrical resistance, or impedance, in the chest throughout the cardiac cycle generates a wave form (Z) based on the path of electrical vectors. Taking the derivative of the Z wave over ventricular ejection time will generate a change in blood volume flowing through the chest, which is the stroke volume.[@R7] From stroke volume, cardiac output can be extrapolated using the patient's heart rate, or more simply by measuring the stroke volume during the course of 1 minute, creating a more accurate measurement of minute to minute cardiac output, given that the stroke volume multiplied by an instantaneous heart rate, which can vary between 70 and 100 beats per minute (bpm) on telemetry monitors in a critically ill patient, will also vary. Similarly, various other hemodynamic parameters can be calculated or estimated from the impedance wave form, including contractility index, stroke volume index, heart rate, cardiac index, systolic blood pressure, diastolic blood pressure, mean arterial pressure, ventricular ejection time, early diastolic filling ratio, left cardiac work index (LCWi), systemic vascular resistance index (SVRi), end diastolic volume, and ejection fraction.[@R8]

The aim of the study was to evaluate the use of non-invasive impedance cardiography to identify additional measurements to be used in the future treatment of sepsis. Its non-invasive approach to obtaining useful hemodynamic variables is appealing for many reasons. In doing so, it may affect the prospective administration of care in critically ill patients.

Methods {#s2}
=======

In our 665-bed independent academic medical center, patients meeting the criteria for severe sepsis alerts, based on the SIRS criteria of the Surviving Sepsis Campaign Guidelines of 2012 ([table 1](#T1){ref-type="table"}), are paged to the surgical emergency service. Nine consecutive patients meeting the criteria for severe sepsis alert were monitored with the PhysioFlow system, a modern platform of impedance cardiography. These patients presented with signs and symptoms to suggest to the presiding emergency medicine attending physician that they had a surgical (i.e., potentially actionable) source of their sepsis. This study was performed during the course of a 3-month period while the PhysioFlow device was on loan from Manatec Biomedical. Impedance electrodes were placed on the anterior chest and neck of each patient in the device's configured arrangement. Measurements were taken at the time of arrival (T^0^) and 1 hour after 2 L intravenous crystalloid solution bolus (T^1^) while in the emergency room. Measurements were used for observation only, and no medical treatment was performed from the data obtained.

###### 

Severe sepsis alert criteria\*

  SIRS† criteria                                 Organ dysfunction variables
  ---------------------------------------------- ----------------------------------------------------------
  Temperature \>38°C or \<36°C                   Systolic blood pressure \<90 mm Hg
  Heart rate \>90 beats per minute               Mean arterial pressure \<65 mm Hg
  Respiratory rate \>20 breaths per minute       \>40% decrease of known baseline systolic blood pressure
  White cell count \<4x10^9^/L or \>12x10^9^/L   Bilirubin, creatinine \> 2mg/dl, lactate \>2meq/L
  Bandemia \>10%                                 Platelets \<100x10^9^/L 
                                                 INR \>1.5 or PTT \>60 sec

Bilirubin and creatinine measured in mg/dl, lactate measured as meq/L

\*A severe sepsis alert was called if a patient met two or more SIRS criteria plus one organ dysfunction variable not explained by an existing medical comorbidity (ie, a chronic cirrhosis with a total bilirubin ≥2 or more).

†SIRS criteria were used in accordance with the 2012 iteration of the Surviving Sepsis Campaign Guidelines.

INR, international normalized ratio; PTT, partial thromboplastin time; SIRS, systemic inflammatory response syndrome.

LCWi is a surrogate for the energy transfer required to perform cardiac output per body surface area measured in kg\*m/m^2^. Additionally, SVRi is a measurement of afterload, whereby the resistance to blood flow is applied across a patient's body surface area. Plotting SVRi against LCWi graphically creates a hemodynamic cross for convenient analysis of a patient with various hemodynamic derangements. This is an added benefit of cardiac impedance used in this study.

Results {#s3}
=======

The mean age of all patients included in this study was 60±17 years. Two were female. Eight were treated for infection (two urosepsis, one liver abscess, two pneumonia, and three soft tissue infection) ([table 2](#T2){ref-type="table"}). Of those with an infection diagnosis, six had positive cultures. One patient meeting the severe sepsis alert criteria had an alternative final diagnosis of sulfa-induced hepatitis. Patients with a diagnosis of urosepsis, liver abscess, and non-infectious etiology were free of medical comorbidities. Alternatively, patients with a diagnosis of pneumonia and soft tissue infection had multiple medical comorbidities, including coronary artery disease, diabetes, chronic kidney disease, and so on. Hemodynamic parameters at presentation and 1 hour after fluid resuscitation were heart rate (bpm) (97±14 and 93±18; p=0.23), mean arterial pressure (mm Hg) (81±13 and 85±14; p=0.55), SVR (dyne-s/cm^−5^) (861±162 and 1087±272; p=0.04), afterload measured as SVRi (dyne\*s/cm^−5^/m^2^) (1813±278 and 2283±497; p=0.04), and LCWi (kg\*m/m^2^) (3.6±1.4 and 3.3±1.2; p=0.69) ([table 3](#T3){ref-type="table"}).

###### 

Patient demographics at presentation and their respective SVRi/LCWi at T^0^ and T^1^

  Patient   Age, sex     Medical history   Final diagnosis           Culture\*                                               Alert criteria†                                                   T^0^   T^1^          
  --------- ------------ ----------------- ------------------------- ------------------------------------------------------- ----------------------------------------------------------------- ------ ------ ------ -----
  1         77, male     DM, Htn, CKD      Soft tissue infection     *Pseudomonas* in foot wound                             HR (120), WCC (1.1), bands (16%), SBP (70), MAP (50), Lac (4.0)   1565   2.4    1740   2.5
  2         77, male     COPD, Htn, CAD    Pneumonia on CXR          None                                                    Temp (38.7), HR (120), WCC (15.2), Lac (3.5)                      2095   2.1    2436   5.0
  3         46, female   None              Urosepsis                 *Citrobacter* in urine and blood                        HR (120), temp (40.2), WCC (13.9), INR (1.6)‡                     1539   4.8    2166   4.1
  4         42, male     None              Sulfa-induced hepatitis   None                                                    Temp (40.3), HR (99), RR (22), WCC (2.5), platelets (82)          1990   2.7    2081   4.4
  5         42, male     CKD, Htn          Soft tissue infection     None                                                    Temp (38.3), WCC (22.4), SBP (76), MAP (51), Cr (7.32)            2035   4.0    2543   1.5
  6         79, male     CKD, CAD          Pneumonia on CXR          None                                                    RR (28), WCC (14), Cr (2.6), Lac (2.2)                            2281   3.8    2420   3.3
  7         33, male     None              Urosepsis                 *Proteus* in urine                                      HR (136), temp (40.1), bands (16%), WCC (21.5), Lac (3.5)         1781   4.3    1445   5.4
  8         68, female   Htn, DM, Hld      Soft tissue infection     Coagulase (−) staphylococci in blood                    Temp (38.7), HR (127), RR (22), WCC (12.5), INR (1.6)‡            1541   7.2    3307   3.5
  9         44, male     None              Liver abscess             Group C streptococci and *Escherichiacoli* in abscess   Temp (38.6), HR (115), WCC (16.6), Cr (3.19)                      1559   5.2    2411   4.4

\*Cultures either not obtained or with negative result listed as "none".

†Alert criteria defined as two or more SIRS criteria in addition to one organ dysfunction variable: SIRS criteria: temperature \>38°C or \<36°C, heart rate \>90 beats per minute, respiratory rate \>20 breaths per minute, white cell count \<4x10^9^/L or \>12x10^9^/L, \>10% bandemia. Organ dysfunction variables: systolic blood pressure \<90 mm Hg, mean arterial pressure \<65 mm Hg, systolic blood pressure drop \>40% of known baseline, bilirubin/creatinine \>2mg/dl, or lactate \>2meq/L, platelets \<100x10^9^/L, INR \>1.5 or activated partial thromboplastin time \>60 seconds.

‡Patients with an elevated INR were not factitiously prolonged due to the effects of coumadin.

Bands, bandemia; CAD, coronary artery disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; Cr, creatinine; CXR, chest X-ray; DM, diabetes mellitus; Hld, hyperlipidemia; HR, heart rate; Htn, hypertension; INR, international normalized ratio; Lac, lactate; LCWi, left cardiac work index; MAP, mean arterial pressure; RR, respiratory rate; SBP, systolic blood pressure; SIRS, systemic inflammatory response syndrome; SVRi, systemic vascular resistance index; T^0^, time prebolus; T^1^, time + 1 hour postbolus; Temp, temperature; WCC, white cell count.

###### 

Hemodynamic parameters at time T^0^ and T^1^

  Parameter                   T^0^ (mean±SD)   T^1^ (mean±SD)   Pearson coefficient   P value\*
  --------------------------- ---------------- ---------------- --------------------- -----------
  SV (mL)                     75.8±15.6        69.9±17.4        0.13                  0.46
  SVi (mL/m^2^)               35.5±6.1         32.9±7.3         −0.03                 0.47
  HR (bpm)                    96.9±13.2        92.8±17.7        0.86                  0.23
  CO (L/min)                  7.3±1.8          6.4±1.8          0.01                  0.32
  CI (L/min/m^2^)             3.4±0.7          3.0±0.8          −0.16                 0.34
  SBP (mm Hg)                 110.8±19.1       110.7±18.6       0.17                  0.98
  DBP (mm Hg)                 59.8±10.4        65.2±12.7        0.32                  0.3
  MAP (mm Hg)                 81.3±12.7        84.9±14.4        0.28                  0.55
  VET (ms)                    273.2±44.4       259.4±39.8       0.39                  0.42
  EDFR (%)                    87.3±26.9        91.1±20.2        0.72                  0.57
  LCWi (kg\*m/m^2^)           3.6±1.4          3.3±1.2          0.01                  0.69
  SVR (dyn\*s/cm^5^)          861±162          1087±272         0.29                  0.04
  SVRi (dyn\*s/cm^5\*^m^2^)   1813±278         2283±497         0.01                  0.04
  EDV (mL)                    142.7±44.2       139.3±32.9       0.4                   0.8
  EF (%)                      55.4±12.5        50.6±7.6         0.38                  0.28

\*P values and Pearson correlation coefficient derived from two-tailed paired t-test.

bpm, beats per minute; CI, cardiac index; CO, cardiac output; DBP, diastolic blood pressure; EDFR, early diastolic filling ratio; EDV, end diastolic volume; EF, ejection fraction; HR, heart rate; LCWi, left cardiac work index; MAP, mean arterial pressure; SBP, systolic blood pressure; SV, stroke volume; SVi, stroke volume index; SVR, systemic vascular resistance; SVRi, systemic vascular resistance index; T^0^, Time prebolus; T^1^, time + 1 hour postbolus; VET, ventricular ejection time.

Discussion {#s4}
==========

The most striking feature of the T^0^ and T^1^ measurements came from the SVR and SVRi parameters. Where the T^0^ mean for SVR was 861 dyn\*s/cm^5^, the T^1^ mean was 1087 dyn\*s/cm^5^, showing a net improvement of 226 dyn\*s/cm^5^ after 2 L crystalloid bolus (p=0.0468). For SVRi, the T^0^ mean was 1813 dyn\*s/cm^5^\*m^2^, whereas the T^1^ mean was 2283 dyn\*s/cm^5^\*m^2^ after fluid resuscitation, showing a net difference of 470 dyn\*s/cm^5^\*m^2^ (p=0.0466). LCWi T^0^ and T^1^ means were 3.61 kg\*m/m^2^ and 3.34 kg\*m/m^2^, showing a difference of 0.27 kg\*m/m^2^ after initial resuscitation. Less significantly, mean arterial pressure at T^0^ and T^1^ was 81 mm Hg and 85 mm Hg (p=0.55), ejection fraction at T^0^ and T^1^ was 55% and 51% (p=0.28; Pearson correlation coefficient 0.38), and ventricular ejection time at T^0^ and T^1^ was 273 ms and 259 ms (p=0.42; Pearson correlation coefficient 0.39).

Impedance cardiography has shown a significant linkage between blood pressure and SVR.[@R10] As SVR increases, blood pressure similarly increases. Given that volume is an important component of blood pressure, it follows logically that volume is an important component of SVR. This is supported by the noted increases in SVR and SVRi observed after fluid challenge in the current investigation ([table 3](#T3){ref-type="table"}).

In patients free of medical comorbidities, the recordings fell into the appropriate quadrant of the hemodynamic cross (LCWi vs. SVRi). Patients with urosepsis had data points within the septic shock territory of the cross ([figure 1](#F1){ref-type="fig"}). The patient with a liver abscess had similar findings. Patients presenting with medical comorbidities had variable data. Patients with pneumonia never had any recordings within the sepsis region of the cross, although they did exhibit appropriate SVR/SVRi changes after crystalloid bolus ([figure 2](#F2){ref-type="fig"}). Patients with soft tissue infection had various starting points, but two patients resulted with hemodynamic readings within the cardiogenic shock quadrant after fluid bolus ([figure 3](#F3){ref-type="fig"}). This finding may suggest volume overload in the setting of acute heart failure.

![Hemodynamic cross charting of patients 3, 7, and 9. LCWi is shown in the y-axis, whereas SVRi is shown in the x-axis. Data plotted from [table 2](#T2){ref-type="table"} (patient 3, a 46-year-old woman with urosepsis; patient 7, a 33-year-old man with urosepsis; patient 9, a 44-year-old man with liver abscess that grew group C streptococcus and *Escherichiacoli*). T^0^ is shown as black circle. T^1^ is shown as white circle. Green, yellow, and red squares represent normal, abnormal, and profoundly abnormal values, respectively. Septic shock shown in the upper left corner identified as low SVRi and high LCWi. Anaphylactic shock shown in the lower left corner identified as low SVRi and low LCWi. Cardiogenic shock shown in the lower right corner identified as high SVRi and low LCWi. Neurogenic hypertension (ie, catecholamine-induced hypertension as would be exhibited in a pheochromocytoma) shown in the upper right corner identified as high SVRi and high LCWi. LCWi, left cardiac work index; SVRi, systemic vascular resistance index. T^0^, time prebolus; T^1^, time + 1 hour postbolus.](tsaco-2019-000349f01){#F1}

![Hemodynamic cross charting of patients 2, 4, and 6. LCWi is shown in the y-axis, whereas SVRi is shown in the x-axis. Data plotted from [table 2](#T2){ref-type="table"} (patient 2, a 77-year-old man with chronic obstructive pulmonary disease who developed pneumonia; patient 4, a 42-year-old man who developed sulfa-induced hepatitis; patient 6, a 79-year-old man who developed pneumonia). T^0^ is shown as black circle. T^1^ is shown as white circle. Green, yellow, and red squares represent normal, abnormal, and profoundly abnormal values, respectively. Septic shock shown in the upper left corner identified as low SVRi and high LCWi. Anaphylactic shock shown in the lower left corner identified as low SVRi and low LCWi. Cardiogenic shock shown in the lower right corner identified as high SVRi and low LCWi. Neurogenic hypertension (ie, catecholamine-induced hypertension as would be exhibited in a pheochromocytoma) shown in the upper right corner identified as high SVRi and high LCWi. LCWi, left cardiac work index; SVRi, systemic vascular resistance index. T^0^, time prebolus; T^1^, time + 1 hour postbolus.](tsaco-2019-000349f02){#F2}

![Hemodynamic cross charting of patients 1, 5 and 8. LCWi is shown in the y-axis, whereas SVRi is shown in the x-axis. Data plotted from [table 2](#T2){ref-type="table"} (patient 1, a 77-year-old man with diabetes with a foot wound growing *Pseudomonas*; patient 5, a 42-year-old man with a soft tissue infection; patient 8, a 68-year-old woman with diabetes with coagulase-negative staphylococci infection and positive blood cultures). T^0^ is shown as black circle. T^1^ is shown as white circle. Green, yellow, and red squares represent normal, abnormal, and profoundly abnormal values, respectively. Septic shock shown in the upper left corner identified as low SVRi and high LCWi. Anaphylactic shock shown in the lower left corner identified as low SVRi and low LCWi. Cardiogenic shock shown in the lower right corner identified as high SVRi and low LCWi. Neurogenic hypertension (ie, catecholamine-induced hypertension as would be exhibited in a pheochromocytoma) shown in the upper right corner identified as high SVRi and high LCWi. LCWi, left cardiac work index; SVRi, systemic vascular resistance index; T^0^, time prebolus; T^1^, time + 1 hour postbolus.](tsaco-2019-000349f03){#F3}

The use of urine output as an indicator of adequate fluid resuscitation can be obscured in patients with pre-existing chronic kidney disease, dialysis dependence, or obstructive nephropathy. In these patients, urine output as a physiologic indicator becomes unreliable. Patients on anticoagulants may show coagulopathy not necessarily attributable to the active disease process of a patient with sepsis, making those values for markers of end-organ dysfunction unreliable. Additionally, any number of physiologic processes may elevate serum lactate (ie, seizures, pulmonary edema, malignancy, hypoglycemia and so on), making them less than unreliable and non-specific toward the diagnosis of sepsis. This emphasizes the need to seek alternative adjunctive, quantifiable measurements for use in diagnosing and resuscitating patients with sepsis.

Several limitations of this study exist, including the small sample size and the lack of providers being blinded to the results. Incidentally, the screening of patients included within this study was ultimately at the discretion of the emergency medicine physician by directing those consults to the general surgery service for presuming a surgical source of their sepsis. Likely during the time period of this study, many patients were referred to the medical intensivist service for sepsis management for which we were not a party to their carecare. Additionally, the severe sepsis alert used in the protocol of this project is based on the dated SIRS criteria, which has been widely criticized for being too non-specific. Furthermore, it has now been replaced with the outcomes-directed assessments of Sequential Organ Failure Assessment and quick Sequential Organ Failure Assessment.[@R11] Further, the exact timing of antibiotic initiation in these patients was not factored into the responses observed on impedance cardiography, as they all received antibiotics at presentation, but at different times from arrival. Lastly, this study was limited to the immediate resuscitation of patients with sepsis with crystalloid boluses---it was not performed on patients requiring vasopressors or during the ongoing management of patients beyond the time required for a 2 L bolus, although, despite these limitations, the data derived from this study show, with statistical significance, a potential use for non-invasive cardiac impedance monitoring in the initial resuscitative phase of sepsis.

Conclusion {#s5}
==========

Impedance cardiography may be useful in the early detection of sepsis. Readings with increased LCWi and, significantly, low SVRi are potential indicators for sepsis. The impedance indices of SVR and SVRi appear to be sensitive to fluid shifts. Similarly, impedance cardiography can identify different varieties of shock. Future studies may solidify the role of impedance cardiography as an adjunct to the management of patients with sepsis.
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